Teva Pharmaceutical Industries earnings were -$993.0M for the trailing 12 months ending Sep 30, 2024, with N/A growth year over year. The latest TEVA earnings report on Sep 30, 2024 announced Q3 2024 earnings of -$437.0M, down 48.3% from last quarter. For the last reported fiscal year 2023 ending Dec 31, 2023, TEVA reported annual earnings of -$559.0M, with -77.1% growth. The next TEVA earnings date is Jan 29, 2025.
Teva Pharmaceutical Industries Earnings Reports & History FAQ
What were Teva Pharmaceutical Industries's earnings last quarter?
On TEVA's earnings call on Invalid Date, Teva Pharmaceutical Industries (NYSE: TEVA) reported Q3 2024 earnings per share (EPS) of -$0.39, up 750% year over year. Total TEVA earnings for the quarter were -$437.00 million. In the same quarter last year, Teva Pharmaceutical Industries's earnings per share (EPS) was $0.06.
When does Teva Pharmaceutical Industries report earnings?
The next TEVA earnings date is Invalid Date. Add TEVA to your watchlist to be reminded of Teva Pharmaceutical Industries's next earnings date.
What was TEVA's earnings growth in the past year?
As of Teva Pharmaceutical Industries's earnings date in Invalid Date, Teva Pharmaceutical Industries's earnings has grown year over year. TEVA earnings in the past year totalled -$993.00 million.
Is Teva Pharmaceutical Industries profitable or losing money?
As of the last Teva Pharmaceutical Industries earnings report, Teva Pharmaceutical Industries is currently losing money. Teva Pharmaceutical Industries's net profit (also called net income) for the twelve months ending Sep 30, 2024 was -$993.00 million, a 57.51% decrease year over year.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.